Relief of benign essential blepharospasm and ? memory loss by cyproheptadine.
These results in a small group of patients seem quite clear for the benefit of cyproheptadine in patients with BEB, especially where botulinum A injections fail, are too expensive, or are refused. The apparent memory improvement requires further study. A search for more effective serotonin antagonists without the anticholinergic and antihistaminic side effects of cyproheptadine is needed and is in process.
Fasanella
R M
RM
D000368:Aged; D001764:Blepharospasm / Q000188:drug therapy*; D003533:Cyproheptadine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008569:Memory Disorders / Q000188:drug therapy*; D008875:Middle Aged
D003533:Cyproheptadine